Anti-Mouse TIM-2 – Purified in vivo GOLD™ Functional Grade
Anti-Mouse TIM-2 – Purified in vivo GOLD™ Functional Grade
Product No.: T762
- -
- -
Clone RMT2-25 Target TIM-2 Formats AvailableView All Product Type Hybridoma Monoclonal Antibody Alternate Names T-cell immunoglobulin and mucin domain-containing protein 2, TIMD-2 Isotype Rat IgG2a κ Applications Agonist , B , FA , FC , IP , WB |
- -
- -
Antibody DetailsProduct DetailsReactive Species Mouse Host Species Rat Recommended Dilution Buffer Immunogen TIM-2-Ig chimera protein consisting of extracellular domain residues 1-230 and the Fc portion of mouse IgG2 Product Concentration ≥ 5.0 mg/ml Endotoxin Level < 1.0 EU/mg as determined by the LAL method Purity ≥95% monomer by analytical SEC ⋅ >95% by SDS Page Formulation This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. State of Matter Liquid Product Preparation Functional grade preclinical antibodies are manufactured in an animal free facility using only in vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Storage and Handling Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles. Regulatory Status Research Use Only Country of Origin USA Shipping 2 – 8° C Wet Ice Additional Applications Reported In Literature ? Agonist, B, FA, FC, IP, WB Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity RMT2-25 activity is directed against mouse TIM-2. Background The T cell/transmembrane, immunoglobulin, and mucin (TIM) family plays a critical role in
immune response, transplant tolerance, autoimmunity, and allergy and asthma regulation1. The
TIM family consists of eight members, including TIM-2 which is only found in rodent genomes.
TIM-2 is likely a gene duplication of TIM-1. TIM-2 is a type I cell surface glycoprotein that has
an N-terminal immunoglobulin-like (Ig) domain, a mucin domain with O- and N-linked
glycosylations, a single transmembrane domain, and a cytoplasmic region with tyrosine
phosphorylation motif. Unlike other TIM family proteins, TIM-2 does not bind PtdSer. TIM-2 is
a receptor for H-ferritin. TIM-2 functions as a negative regulator of T cell activation and Th2
responses. RMT2-25 was generated by immunizing Sprague Dawley rats with a TIM-2-Ig chimera protein consisting of murine TIM-2-Ig (extracellular domain residues 1-230) and the Fc portion of mouse IgG2a2 . LN cells were fused with P3U1 myeloma cells. The RMT2-25 hybridoma was selected using flow cytometry, based on reactivity to mouse TIM-2 transfected cells, but not parental cells. RMT2-25 inhibits the binding of H-ferritin to TIM-2. RMT2-25 also significantly enhances B cell proliferation and activation in vitro by agonistic stimulation of TIM-2. Antigen Distribution TIM-2 is expressed by activated T cells, particularly after differentiation
under Th2 conditions. TIM-2 is not expressed by T cells differentiated under Th1 conditions.
TIM-2 is also expressed by splenic and germinal B cells. Other cells expressing TIM-2 include
epithelial cells in the liver and kidney as well as oligodendrocytes. Ligand/Receptor Sema4A, H-ferritin NCBI Gene Bank ID UniProt.org Research Area Autoimmune . Immunology . Immunoglobulins References & Citations1 Freeman GJ, Casasnovas JM, Umetsu DT, et al. Immunol Rev. 235(1):172-189. 2010. 2 Kawamoto T, Abe Y, Ito J, et al. Arthritis Res Ther. 13(2):R47. 2011. Technical ProtocolsCertificate of Analysis |
Formats Available
